Medical Marketing Insights

The FDA’s new Action Plan focuses on safely reducing regulations — which creates opportunities for patients, medical providers, and marketers in the process.

Last year, the FDA put a considerable amount of energy into the digital health technology approval process. Will these efforts carry into 2018?

New guidelines from the FDA give clinical trials concrete recommendations on mHealth for today and confidence for the future.

Clinical trial sponsors know that any direct-to-patient advertising must secure IRB approval — but what does this mean in the digital age?

A friendly reminder that, with the recent HHS Office of Civil Rights announcement, covered entities may soon be facing some unwelcome audits. Now’s the time to review compliance.